• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec11
Nexgel Splits Off Drug Delivery Unit as NexGelRx
13:00
Nov13
Maxim Group Analyst Reiterates Buy Rating on NexGel Inc
13:22
Nexgel released FY2025 9 Months Earnings on November 12 After-Market EST, Actual Revenue: USD 8.624 M, Actual EPS: USD -0.265
00:00
Nexgel released FY2025 Q3 earnings on November 12 After-Market EST, actual revenue USD 2.934 M (forecast USD 3.164 M), actual EPS USD -0.0819 (forecast USD -0.08)
00:00
Nov4
Nexgel to release FY2025 Q3 earnings on November 11 After-Market EST, forecast revenue USD 3.164 M, EPS USD -0.08
00:09
Aug12
Nexgel released FY2025 Q2 earnings on August 12 After-Market (EST), actual revenue USD 2.884 M (forecast USD 3.08 M), actual EPS USD -0.0899 (forecast USD -0.07)
23:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 2.934 M, Net Income -653 K, EPS -0.0819

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.884 M, Net Income -665 K, EPS -0.0899

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 2.806 M, Net Income -712 K, EPS -0.0931

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
RADX
11.131
+161.29%
+6.871
AMCI
6.270
+131.37%
+3.560
ARTV
6.110
+85.15%
+2.815
KXIN
5.399
+62.61%
+1.960
MASK
0.4344
+44.46%
+0.133
ASTI
4.380
+40.39%
+1.260
QIPT
3.505
+34.29%
+0.895
NTCL
0.8798
+29.38%
+0.200
CLYM
3.880
+29.32%
+0.879
KYTX
10.975
+25.00%
+2.195
View More